1,676
Views
74
CrossRef citations to date
0
Altmetric
Original Articles

Lessons from the Vioxx Debacle: What the Privatization of Science Can Teach Us About Social Epistemology

Pages 21-39 | Published online: 11 Apr 2007

References

  • Abrams , T. W. 2001 . “Warning letter to Raymond G. Gilmartin, president and CEO of Merck & Co., Inc.” 17 September [cited 2 January 2007]. Available from http://www.fda.gov/foi/warning_letters/g1751d.pdf ; INTERNET
  • Angell , M. 2004 . The truth about the drug companies: How they deceive us and what to do about it , New York : Random House .
  • Avorn , J. 2004 . Powerful medicines: The benefits, risks, and costs of prescription drugs , New York : Alfred A. Knopf .
  • Bekelman , J. E. , Li , Y. and Gross , C. P. 2003 . Scope and impact of financial conflicts of interest in biomedical research: A systematic review . Journal of the American Medical Association , 289 : 454 – 65 .
  • Berenson , A. 2005a . “ Evidence in Vioxx suits shows intervention by Merck officials ” . In New York Times 24 April [cited 2 January 2007]. Available from http://www.nytimes.com/2005/04/24/business/24drug.html; INTERNET
  • Berenson , A. 20 August 2005b . “ Jury calls Merck liable in death of man on Vioxx ” . In New York Times 20 August ,
  • Berenson , A. 2005c . “ For Merck, Vioxx paper trail won’t go away ” . In New York Times 21 August [cited 2 January 2007]. Available from http://www.nytimes.com/2005/08/21/business/21vioxx.html; INTERNET
  • Berenson , A. , Harris , G. , Meier , B. and Pollack , A. 14 November 2004 . “ Dangerous Data: Despite warnings, drug giant took long path to Vioxx recall ” . In New York Times 14 November , [cited 2 January 2007]. Available from http://www.nytimes.com/2004/11/14/business/14merck.html; INTERNET
  • Biddle , J. 2006 . Socializing science: On the epistemic significance of the institutional context of science , University of Notre Dame . Ph.D. diss.
  • Bok , D. 2003 . Universities in the markeplace: The commercialization of higher education , Princeton, NJ : Princeton University Press .
  • Bombardier , C. , Laine , L. , Reicin , A. , Shapiro , D. , Burgos‐Vargas , R. Davis , B. 2000 . Comparison of upper gastrointestinal toxicity of Rofecoxib and Naproxen in patients with rheumatoid arthritis . New England Journal of Medicine , 343 : 1520 – 28 .
  • Bombardier , C. , Laine , L. , Burgos‐Vargas , R. , Davis , B. , Day , R. Bossi Ferraz , M. 2006 . Response to expression of concern regarding VIGOR study . New England Journal of Medicine , 354 : 1196 – 99 .
  • Brown , J. R. 2000 . Privatizing the university—The new tragedy of the commons . Science , 290 : 1701 – 02 .
  • Brown , J. R. Forthcoming . “ The community of science ” . In Science and the social: Knowledge, epistemic demands, and social values Edited by: Carrier , M. , Howard , D. and Kourany , J.
  • Brown , M. 2004 . The political philosophy of science policy . Minerva , 42 : 77 – 95 .
  • Carrier , M. Forthcoming . “ Science in the grip of the economy: Privatization of research and public accessibility to knowledge ” . In Science and the social: Knowledge, epistemic demands, and social values Edited by: Carrier , M. , Howard , D. and Kourany , J.
  • Cauchon , D. 25 September 2000 . “ FDA advisors tied to industry ” . In USA Today 25 September ,
  • Center for Science in the Public Interest . 25 February 2005 . “Conflicts of interest on COX‐2 panel.” 25 February , [cited 2 January 2007]. Available from http://www.cspinet.org/new/200502251.html; INTERNET.
  • Cho , M. K. and Bero , L. A. 1996 . The quality of drug studies published in symposium proceedings . Annals of Internal Medicine , 124 : 485 – 89 .
  • Conant , J. 1951 . Science and common sense , New Haven : Yale University Press .
  • Conant , J. 1952 . Modern science and modern man , New York : Columbia University Press .
  • Curfman , G. D. , Morrissey , S. and Drazen , J. M. 2005 . Expression of concern: Bombardier et al., “Comparison of upper gastrointestinal toxicity of Rofecoxib and Naproxen in patients with rheumatoid arthritis,” . N Eng J Med 2000 , 343 : 1520 – 8 . New England Journal of Medicine 353: 2813–14.
  • Curfman , G. D. , Morrissey , S. and Drazen , J. M. 2006 . Expression of concern reaffirmed . New England Journal of Medicine , 354 : 1193
  • DePaul , M. and Zagzebski , L. , eds. 2003 . Intellectual virtue: Perspectives from ethics and epistemology , Oxford : Oxford University Press .
  • Feder , B. J. 5 November 2004 . “ Lawyers organising for mass suits over Vioxx ” . In New York Times 5 November ,
  • Fine , A. 1988 . “ Interpreting science ” . In Proceedings of the 1988 biennial meeting of the Philosophy of Science Association , Edited by: Fine , A. and Leplin , J. volume 2 , Michigan : Philosophy of Science Association . East Lansing
  • Fontanarosa , P. B. , Rennie , D. and DeAngelis , C. D. 2004 . Postmarketing surveillance—Lack of vigilance, lack of trust . Journal of the American Medical Association , 292 : 2647 – 50 .
  • Friedberg , M. , Saffran , B. , Stinson , T. J. , Nelson , W. and Bennett , C. L. 1999 . Evaluation of conflict of interest in economic analyses of new drugs used in oncology . Journal of the American Medical Association , 282 : 1453 – 57 .
  • Government Accountability Office . 2006 . “Drug safety: Improvement needed in FDA’s postmarket decision making and oversight process.” [cited 18 May 2006]. Available from http://files.findlaw.com/news.findlaw.com/nytimes/docs/fda/gaorptfdadrugsafety42106.pdf; INTERNET.
  • Harris , G. 6 December 2004 . “ At F.D.A., strong drug ties and less monitoring ” . In New York Times 6 December ,
  • Harris , G. 2 March 2005 . “ F.D.A. official admits “lapses” on Vioxx ” . In New York Times 2 March ,
  • Hilts , P. J. 2003 . Protecting America’s health: The FDA, business, and one hundred years of regulation , Chapel Hill, NC : University of North Carolina Press .
  • Kantrowitz , A. 1967 . Proposal for an institution for scientific judgment . Science , 156 : 763 – 64 .
  • Kantrowitz , A. 1976 . The science court experiment: An interim report . Science , 193 : 653 – 56 .
  • Kitcher , P. 1993 . The advancement of science: Science without legend, objectivity without illusions , New York : Oxford University Press .
  • Kitcher , P. 2001 . Science, truth, and democracy , New York : Oxford University Press .
  • Kitcher , P. 2002a . The third way: Reflections on Helen Longino’s The fate of knowledge. . Philosophy of Science , 69 : 549 – 59 .
  • Kitcher , P. 2002b . Reply to Helen Longino . Philosophy of Science , 69 : 569 – 72 .
  • Konstam , M. A. , Weir , M. R. , Reicin , A. , Shapiro , D. , Sperling , R. S. , Barr , E. and Gertz , B. J. 2001 . Cardiovascular thrombotic events in controlled, clinical trials of Rofecoxib . Circulation , 104 : 2280 – 88 .
  • Kourany , J. Forthcoming . “ Replacing the ideal of value‐free science ” . In Science and the social: Knowledge, epistemic demands, and social values Edited by: Carrier , M. , Howard , D. and Kourany , J.
  • Krimsky , S. 2003 . Science in the private interest: Has the lure of profits corrupted biomedical research? , Lanham, MD : Rowman & Littlefield .
  • Lisse , J. R. , Perlman , M. , Johansson , G. , Shoemaker , J. R. , Schechtman , J. Skalky , C. S. 2003 . Gastrointestinal tolerability and effectiveness of Rofecoxib versus Naproxen in the treatment of osteoarthritis . Annals of Internal Medicine , 139 : 539 – 46 .
  • Longino , H. 1990 . Science as social knowledge , Princeton : Princeton University Press .
  • Longino , H. 2002a . The fate of knowledge , Princeton : Princeton University Press .
  • Longino , H. 2002b . Thoughts on Philip Kitcher’s Science, truth, and democracy. . Philosophy of Science , 69 : 560 – 68 .
  • Longino , H. 2002c . Reply to Philip Kitcher . Philosophy of Science , 69 : 573 – 77 .
  • Matthews , A. N. and Martinez , B. 2004 . Warning Signs: Emails suggest Merck knew Vioxx’s dangers at early stage . Wall Street Journal , 1 November [cited 2 January 2007]. Available from http://online.wsj.com/article/SB109926864290160719.html; INTERNET
  • Merton , R. K. 1942 . A note on science and technology in a democratic order . Journal of Legal and Political Sociology , 1 : 115 – 26 .
  • Mirowski , P. and Sent , E. 2002 . “ Introduction ” . In Science bought and sold: essays in the economics of science , Edited by: Mirowski , P. and Sent , E. Chicago : University of Chicago Press .
  • Mukherjee , D. M. , Nissen , S. E. and Topol , E. J. 2001 . Risk of cardiovascular events associated with selective COX‐2 inhibitors . Journal of the American Medical Association , 286 : 954 – 59 .
  • Ray , W. A. , Stein , C. M. , Hall , K. , Arbogast , P. G. , Daugherty , J. R. and Griffin , M. R. 2002 . Non‐steroidal anti‐inflammatory drugs and risk of serious coronary heart disease: an observational cohort study . The Lancet , 359 : 118 – 23 .
  • Slaughter , S. and Rhoades , G. 1996 . The emergence of a competitiveness research and development policy coalition and the commercialization of academic science and technology . Science, Technology, and Human Values , 21 : 303 – 39 .
  • Solomon , M. 2001 . Social empiricism , Cambridge : MIT Press .
  • Solomon , M. and Richardson , A. 2005 . A critical context for Longino’s critical contextual empiricism . Studies in the History and Philosophy of Science , 36 : 211 – 22 .
  • Stelfox , H. T. , Chua , G. , O’Rourke , G. K. and Detsky , A. S. 1998 . Conflict of interest in the debate over calcium‐channel antagonists . New England Journal of Medicine , 338 : 101 – 06 .
  • Topol , E. J. 2004 . Failing the public health—Rofecoxib, Merck, and the FDA . New England Journal of Medicine , 351 : 1707 – 09 .
  • United States Senate Committee on Finance . 2004 . “Grassley questions Merck about communication with the FDA on Vioxx.” [cited 19 May 2006]. Available from http://www.senate.gov/~finance/press/Gpress/2004/prg101504.pdf; INTERNET.
  • Wilholt , T. Forthcoming . “ Design rules: Industrial research and epistemic merit ” . In Philosophy of science

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.